High at the End
I’m not sure when we stopped researching LSD. Forty years ago, apparently. A Swiss psychiatrist named Peter Gasser decided to change that. He gave high doses to twelve terminal cancer patients—most of them had never taken acid—and watched what happened.
The anxiety dropped. The depression dropped. The specific kind of dread that comes with being told you’re dying: that lifted too. And it stayed lifted. A year later, these people were still reporting the same peace they’d felt in the clinic. No one freaked out. No one had a bad trip. The experiment worked.
Half the group got placebo first. Their conditions got worse. Then they got the real thing, and they improved. That’s not magic or placebo effect. That’s just pharmacology.
What stuck with me is that eleven of the twelve said they’d take it again. Not because they were chasing fun. Because they’d spent a few hours without the weight they’d been carrying for months. That mattered enough to them that they wanted to remember how to get back there.
I’ve taken acid. I’ve been in clubs at three in the morning surrounded by people convinced they were experiencing something profound. Some of it was bullshit. But the mechanism is the same whether you’re in a basement or in a hospital bed. The drug works on your brain. It makes things feel less final. It opens up space where there was only closure.
The difference is context. In a club, it’s just chemicals and music and the possibility of something. In a cancer ward, it’s the possibility of relief from something unbearable.
We should probably run more studies. One study of twelve people isn’t enough to change medicine. But it’s enough to suggest that maybe we got it wrong. Maybe the drug itself isn’t the enemy. Maybe it’s the use that matters. Maybe fear of drugs has prevented us from looking at something that could genuinely help the people we fail most: the ones we’re about to lose.